MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
Genes involved in the carcinogenetic mechanisms underlying malignant pleural mesothelioma (MPM) are still poorly characterized. So far, mesothelin (MSLN) has aroused the most interest. It encodes for a membrane glycoprotein, frequently over-expressed in various malignancies such as MPM, and ovarian...
Saved in:
| Main Authors: | Ombretta Melaiu, Justin Stebbing, Ylenia Lombardo, Elisa Bracci, Norihisa Uehara, Alessandra Bonotti, Alfonso Cristaudo, Rudy Foddis, Luciano Mutti, Roberto Barale, Federica Gemignani, Georgios Giamas, Stefano Landi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0085935 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
by: Ombretta Melaiu, et al.
Published: (2017-01-01) -
KRAS signaling in malignant pleural mesothelioma
by: Antonia Marazioti, et al.
Published: (2021-12-01) -
A Diagnostic Approach to Malignant Pleural Mesothelioma
by: Avinash Aujayeb, et al.
Published: (2025-06-01) -
Malignant pleural mesothelioma with rarely seen metastases
by: Elif Şenocak Taşçı, et al.
Published: (2017-12-01) -
Malignant Mesothelioma after Household Exposure to Asbestos
by: Raya Saba, et al.
Published: (2013-01-01)